Abstract

Respiratory viral infections, including COVID-19, Respiratory Syncytial Virus (RSV), and Influenza, continue to be major public health concerns worldwide. These viruses share common clinical presentations, yet differ significantly in their pathogenesis, clinical outcomes, and available therapeutic interventions. This article provides a comparative analysis of COVID-19, RSV, and Influenza, highlighting the underlying mechanisms of infection, disease progression, and the current therapeutic strategies. We aim to elucidate the distinctive and overlapping characteristics of these respiratory viruses, with a focus on diagnostic challenges, clinical management, and the impact of public health measures. Understanding these differences and similarities will aid in improving treatment protocols and preparedness for future viral pandemics.